[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
August 12, 2009

Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus

JAMA. 2009;302(6):624-625. doi:10.1001/jama.2009.1098

To the Editor: Dr Couri and colleagues1 provided a follow-up study of patients with newly diagnosed type 1 diabetes mellitus treated with autologous nonmyeloablative hematopoietic stem cell transplantation. The authors noted that 160 patients were screened, but only 23 were enrolled. To further evaluate the possible generalizability of these findings, it would be helpful to know why screened patients were not eligible and why eligible patients elected not to participate.

First Page Preview View Large
First page PDF preview
First page PDF preview
×